Driver mutations occur frequently in metastases of well‐differentiated small intestine neuroendocrine tumours

Abstract

Driver mutations occur in 50% of metastasised SI-NETs, and their presence is associated with a high Ki67 proliferation index. The identification of targetable mutations make these patients potentially eligible for targeted therapy.